近日，一家专注于利用机器学习检测工厂病原体的初创公司Spore.Bio宣布获得800万欧元的Pre-seed轮融资。此轮融资由LocalGlobe领投，旨在解决全球快速消费品（FMCG）市场所面临的的关键健康和安全挑战。
Spore.Bio公司研发了全球首台可直接在工厂车间检测病原体的设备。该设备采用先进的机器学习模型进行训练，能识别食品、饮料、药品和化妆品中的细菌浓度，并及时提醒质量经理潜在风险。此技术的出现，将为我国及全球消费品行业带来革命性的变革。
此次融资将主要用于推动Spore.Bio的技术研发和市场拓展，进一步优化检测设备，提高检测精度，以确保全球消费者的健康安全。
英文翻译：
News Title: Startup Spore.Bio Secures €8 Million Pre-seed Round to Tackle Global Health and Safety Challenges in Fast-Moving Consumer Goods Market
Keywords: Spore.Bio, Financing, Pathogen Detection
News Content:
Recently, Spore.Bio, a startup focused on using machine learning to detect pathogens in factories, announced that it has raised €8 million in a Pre-seed round of financing. The round was led by LocalGlobe, aiming to address the critical health and safety challenges faced by the global fast-moving consumer goods (FMCG) market.
Spore.Bio has developed the world’s first device that can detect pathogens directly in factory workshops. The device uses advanced machine learning models for training, recognizing bacterial concentrations in food, beverages, pharmaceuticals, and cosmetics, and promptly alerting quality managers to potential risks. The emergence of this technology will bring about a revolutionary change in the consumer goods industry in our country and around the world.
The financing will be used to promote Spore.Bio’s technology development and market expansion, further optimize the detection equipment, and improve detection accuracy to ensure the health and safety of consumers worldwide.
【来源】https://tech.eu/2023/12/12/sporebio-raises-eur8m-for-real-time-pathogen-detection-in-fmcg-factories/
Views: 4